Business Description
Procter & Gamble Health Ltd
ISIN : INE199A01012
Share Class Description:
BOM:500126: Shs DematerialisedCompare
Compare
Traded in other countries / regions
PGHL.India IPO Date
1992-03-02Description
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 40.14 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 383.03 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 19.96 | |||||
| Beneish M-Score | -2.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.5 | |||||
| 3-Year EBITDA Growth Rate | 31 | |||||
| 3-Year EPS without NRI Growth Rate | 33.4 | |||||
| 3-Year Book Growth Rate | -21.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.51 | |||||
| 9-Day RSI | 44.73 | |||||
| 14-Day RSI | 41.13 | |||||
| 6-1 Month Momentum % | -2.4 | |||||
| 12-1 Month Momentum % | 4.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.35 | |||||
| Quick Ratio | 2.79 | |||||
| Cash Ratio | 1.88 | |||||
| Days Inventory | 141.29 | |||||
| Days Sales Outstanding | 34.78 | |||||
| Days Payable | 207.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.11 | |||||
| Dividend Payout Ratio | 0.7 | |||||
| 3-Year Dividend Growth Rate | 55.6 | |||||
| Forward Dividend Yield % | 2.11 | |||||
| 5-Year Yield-on-Cost % | 18.1 | |||||
| Shareholder Yield % | 2.09 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.97 | |||||
| Operating Margin % | 23.22 | |||||
| Net Margin % | 18.32 | |||||
| FCF Margin % | 15.64 | |||||
| ROE % | 29.68 | |||||
| ROA % | 20.87 | |||||
| ROIC % | 48.65 | |||||
| ROC (Joel Greenblatt) % | 127.21 | |||||
| ROCE % | 38.33 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.49 | |||||
| PE Ratio without NRI | 34.74 | |||||
| Shiller PE Ratio | 29.95 | |||||
| Price-to-Owner-Earnings | 38.14 | |||||
| PEG Ratio | 1.78 | |||||
| PS Ratio | 6.31 | |||||
| PB Ratio | 9.7 | |||||
| Price-to-Tangible-Book | 9.76 | |||||
| Price-to-Free-Cash-Flow | 40.39 | |||||
| Price-to-Operating-Cash-Flow | 33.11 | |||||
| EV-to-EBIT | 23.91 | |||||
| EV-to-EBITDA | 22.07 | |||||
| EV-to-Revenue | 6 | |||||
| EV-to-FCF | 38.11 | |||||
| Price-to-Projected-FCF | 5.11 | |||||
| Price-to-DCF (Earnings Based) | 1.93 | |||||
| Price-to-DCF (FCF Based) | 4.38 | |||||
| Price-to-Median-PS-Value | 1.04 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.72 | |||||
| Price-to-Graham-Number | 3.89 | |||||
| Price-to-Net-Current-Asset-Value | 15.72 | |||||
| Price-to-Net-Cash | 48.42 | |||||
| Earnings Yield (Greenblatt) % | 4.19 | |||||
| FCF Yield % | 2.46 | |||||
| Forward Rate of Return (Yacktman) % | 20.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Procter & Gamble Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 12,370 | ||
| EPS (TTM) (₹) | 136.53 | ||
| Beta | 0.03 | ||
| Volatility % | 20.1 | ||
| 14-Day RSI | 41.13 | ||
| 14-Day ATR (₹) | 81.223757 | ||
| 20-Day SMA (₹) | 4752.9475 | ||
| 12-1 Month Momentum % | 4.07 | ||
| 52-Week Range (₹) | 4595.85 - 5640 | ||
| Shares Outstanding (Mil) | 16.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Procter & Gamble Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Procter & Gamble Health Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Procter & Gamble Health Ltd Frequently Asked Questions
What is Procter & Gamble Health Ltd(BOM:500126)'s stock price today?
The current price of BOM:500126 is ₹4736.35. The 52 week high of BOM:500126 is ₹5640.00 and 52 week low is ₹4595.85.
When is next earnings date of Procter & Gamble Health Ltd(BOM:500126)?
The next earnings date of Procter & Gamble Health Ltd(BOM:500126) is .
Does Procter & Gamble Health Ltd(BOM:500126) pay dividends? If so, how much?
The Dividend Yield %  of Procter & Gamble Health Ltd(BOM:500126) is 2.11% (As of Today), Highest Dividend Payout Ratio of Procter & Gamble Health Ltd(BOM:500126) was 0.7. The lowest was 0.07. And the median was 0.33. The  Forward Dividend Yield % of Procter & Gamble Health Ltd(BOM:500126) is 2.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers